Clinical Trial Update: HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hematopoietic stem cell transplantation using risk-adjusted chemotherapy for patients with Fanconi anemia and severe marrow failure (in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Fanconi Anemia
• Myelodysplastic Syndrome

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Fanconi Anemia, Severe Marrow Failure | Phase 2 | Status: RECRUITING